DB-029.01

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameDB-029.01

Drug Alias NameAAV gene therapy (Digna)AAV-Apolinker-P144

ClassificationBiologics > Protein drugs > Recombinant polypeptideCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of ActionTransforming growth factor beta receptors antagonists

TargetsTransforming growth factor beta receptors

Therapy Area/IndicationsPulmonary FibrosisNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesDigna Biotech Sl

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesDigna Biotech Sl

Active IndicationsN/A

Inactive IndicationsPulmonary FibrosisNeoplasms

Other Information

ATC CodeN/A